Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study
Rooks, Daniel, Praestgaard, Jens, Hariry, Sam, Laurent, Didier, Petricoul, Olivier, Perry, Robert G., Lach‐Trifilieff, Estelle, Roubenoff, Ronenn
Published in Journal of the American Geriatrics Society (JAGS) (01.09.2017)
Published in Journal of the American Geriatrics Society (JAGS) (01.09.2017)
Get full text
Journal Article
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
Dörner, Thomas, Posch, Maximilian Georg, Li, Yue, Petricoul, Olivier, Cabanski, Maciej, Milojevic, Julie Marie, Kamphausen, Esther, Valentin, Marie-Anne, Simonett, Claudia, Mooney, Louise, Hüser, Andreas, Gram, Hermann, Wagner, Frank Dietrich, Oliver, Stephen John
Published in Annals of the rheumatic diseases (01.05.2019)
Published in Annals of the rheumatic diseases (01.05.2019)
Get full text
Journal Article
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
Rooks, Daniel, Petricoul, Olivier, Praestgaard, Jens, Bartlett, Michael, Laurent, Didier, Roubenoff, Ronenn
Published in Journal of cachexia, sarcopenia and muscle (01.12.2020)
Published in Journal of cachexia, sarcopenia and muscle (01.12.2020)
Get full text
Journal Article
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial
Heymsfield, Steven B, Coleman, Laura A, Miller, Ram, Rooks, Daniel S, Laurent, Didier, Petricoul, Olivier, Praestgaard, Jens, Swan, Therese, Wade, Thomas, Perry, Robert G, Goodpaster, Bret H, Roubenoff, Ronenn
Published in JAMA network open (04.01.2021)
Published in JAMA network open (04.01.2021)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
Petricoul, Olivier, Nazarian, Arman, Schuehly, Uwe, Schramm, Ursula, David, Olivier J., Laurent, Didier, Praestgaard, Jens, Roubenoff, Ronenn, Papanicolaou, Dimitris A., Rooks, Daniel
Published in Clinical pharmacokinetics (2023)
Published in Clinical pharmacokinetics (2023)
Get full text
Journal Article
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence
Hach, Thomas, Shakeri-Nejad, Kasra, Bigaud, Marc, Dahlke, Frank, de Micco, Massimiliano, Petricoul, Olivier, Graham, Gordon, Piani-Meier, Daniela, Turrini, Renato, Brinkmann, Volker, Nicoletti, Ferdinando
Published in Journal of interferon & cytokine research (01.06.2023)
Published in Journal of interferon & cytokine research (01.06.2023)
Get more information
Journal Article
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
Garito, Tania, Roubenoff, Ronenn, Hompesch, Marcus, Morrow, Linda, Gomez, Katherine, Rooks, Daniel, Meyers, Charles, Buchsbaum, Monte S., Neelakantham, Srikanth, Swan, Therese, Filosa, Lee Anne, Laurent, Didier, Petricoul, Olivier, Zakaria, Marjorie
Published in Diabetes, obesity & metabolism (01.01.2018)
Published in Diabetes, obesity & metabolism (01.01.2018)
Get full text
Journal Article
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
Garito, Tania, Zakaria, Marjorie, Papanicolaou, Dimitris A., Li, Yifang, Pinot, Pascale, Petricoul, Olivier, Laurent, Didier, Rooks, Daniel, Rondon, Juan Carlos, Roubenoff, Ronenn
Published in Clinical endocrinology (Oxford) (01.06.2018)
Published in Clinical endocrinology (Oxford) (01.06.2018)
Get full text
Journal Article
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial
Grunseich, Christopher, Miller, Ram, Swan, Therese, Glass, David J, El Mouelhi, Mohamed, Fornaro, Mara, Petricoul, Olivier, Vostiar, Igor, Roubenoff, Ronenn, Meriggioli, Matthew N, Kokkinis, Angela, Guber, Robert D, Budron, Maher S, Vissing, John, Soraru, Gianni, Mozaffar, Tahseen, Ludolph, Albert, Kissel, John T, Fischbeck, Kenneth H, Grunseich, Christopher, Miller, Ram, Swan, Therese, Glass, David J, Mouelhi, Mohamed El, Fornaro, Mara, Petricoul, Olivier, Vostiar, Igor, Roubenoff, Ronenn, Meriggioli, Matthew N, Dahlqvist, Julia, Witting, Nanna, Vissing, John, Martinelli, Ilaria, Querin, Giorgia, Soraru, Gianni, Goyal, Namita A, Cash, Tiyonnoh M, Minton, Brian, Mozaffar, Tahseen, Rosenbohm, Angela, Weiland, Ulrike, Weydt, Patrick, Ludolph, Albert, Chelnick, Sharon, Iyadurai, Stanley, King, Wendy, Kissel, John T, Budron, Maher S, Guber, Robert D, Kokkinis, Angela, Fischbeck, Kenneth H
Published in Lancet neurology (01.12.2018)
Published in Lancet neurology (01.12.2018)
Get full text
Journal Article
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial
Rooks, Daniel, Swan, Therese, Goswami, Budhaditya, Filosa, Lee Anne, Bunte, Ola, Panchaud, Nicolas, Coleman, Laura A, Miller, Ram R, Garcia Garayoa, Elisa, Praestgaard, Jens, Perry, Robert G, Recknor, Chris, Fogarty, Charles M, Arai, Hidenori, Chen, Liang-Kung, Hashimoto, Jun, Chung, Yoon-Sok, Vissing, John, Laurent, Didier, Petricoul, Olivier, Hemsley, Sarah, Lach-Trifilieff, Estelle, Papanicolaou, Dimitris A, Roubenoff, Ronenn
Published in JAMA network open (01.10.2020)
Published in JAMA network open (01.10.2020)
Get full text
Journal Article
A randomized, placebo-controlled study to evaluate the safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy
Grunseich, Christopher, Miller, Ram, Swan, Therese, Glass, David J, El Mouelhi, Mohamed, Fornaro, Mara, Petricoul, Olivier, Vostiar, Igor, Roubenoff, Ronenn, Meriggioli, Matthew N, Kokkinis, Angela, Guber, Robert D, Budron, Maher S, Vissing, John, Soraru, Gianni, Mozaffar, Tahseen, Ludolph, Albert, Kissel, John T, Fischbeck, Kenneth H
Published in Lancet neurology (15.10.2018)
Published in Lancet neurology (15.10.2018)
Get full text
Journal Article
Phase I Study of IPH1101 (with Low Dose of IL-2) in Patient with B-NHL
Rossi, Jean François, Rouillé, Valerie, de Micheaux, Sylvie Lafaye, Sicard, Hélène, Pétricoul, Olivier, Beautier, Lucile, d'Arnoux, Christine, Kunzmann, Volker
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
TREATMENT FOR LUPUS NEPHRITIS USING ANTI-BAFFR ANTIBODIES
PETRICOUL, Olivier, OLIVER, Stephen, BALTCHEVA, Irina, HUEBER, Wolfgang
Year of Publication 18.07.2024
Get full text
Year of Publication 18.07.2024
Patent
TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING ANTI-BAFFR ANTIBODIES
PETRICOUL, Olivier, OLIVER, Stephen, BALTCHEVA, Irina, HUEBER, Wolfgang
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent
Clinical pharmacokinetics of intranasal sumatriptan
Fuseau, Eliane, Petricoul, Olivier, Moore, Katy H P, Barrow, Andrew, Ibbotson, Tim
Published in Clinical pharmacokinetics (2002)
Published in Clinical pharmacokinetics (2002)
Get full text
Journal Article
TREATMENT FOR LUPUS NEPHRITIS USING ANTI-BAFFR ANTIBODIES
PETRICOUL, Olivier, OLIVER, Stephen, BALTCHEVA, Irina, HUEBER, Wolfgang
Year of Publication 13.03.2024
Get full text
Year of Publication 13.03.2024
Patent
TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING ANTI-BAFFR ANTIBODIES
PETRICOUL, Olivier, OLIVER, Stephen, BALTCHEVA, Irina, HUEBER, Wolfgang
Year of Publication 13.03.2024
Get full text
Year of Publication 13.03.2024
Patent